Apligraf: Marketed to treat venous ulcers of >1 month duration that have resisted healing with traditional treatment

Data from the 136 patients who were randomized to compression therapy in Apligraf's pivotal trial showed that patients who did not heal with compression therapy demonstrated less healing progress duri...